ClinicalTrials.gg
RecruitingNCT07766044Updated Sep 2, 2026

A One-year Follow-up of Incisional Hernia Formation Between Device Assisted and Manual Laparotomy Closure

An interventional study of Device assisted laparotomy closure and Manual laparotomy closure in Incisional Hernia After Midline Laparotomy and Colorectal Cancer, sponsored by Suturion AB. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Suturion AB · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
218
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The study compares one-year incisional hernia formation between two cohorts of patients that underwent open surgery for colorectal diseases. The patients had the abdominal wall closure performed with either a device for standardized closure or manual closure.

The devices aims to secure the closure technique that is advocated by guidelines and could potentially reduce abdominal wall complications. Upholding closure quality can be cumbersome and time consuming and hence inferior closure can sometimes be associated with manual closure.

Follow-up will include short term complications like wound infection and burst abdomen and one-year follow-up include a review of patients chart and CTscans performed as part of standard clinical practice.

Read the detailed description

This is a single center retrospective study, comparing short and long term abdominal wall related complications among a cohort of 38 patients that underwent abdominal wall closure with a device for standardized laparotomy closure, and a cohort of 180 patients that underwent closure with manual technique during 2020 to 2023.

Included patients were selected for open surgery for colorectal disease according to institutions standard practice. Patients will be identified from a previous study on the device for standardized laparotomy closure and the controls will be identified through the operation administrative system.

Data on short term complications will be retrieved from the patients chart and incisional hernia will be identified by reviewing the CTscans performed as a part of the standard clinical pathway. Reviewing will be performed according to the EHS classification for incisional hernia by two radiologists blinded for the closure technique.

External statistic analysis will be perfromed. Data will be disseminated as a scientific publication.

02

Conditions studied

  • Incisional Hernia After Midline Laparotomy
  • Colorectal Cancer

Keywords

  • Laparotomy
  • Incisional hernia
  • Device assisted closure
  • Small-bites
  • Burst abdomen
  • Wound infection
  • Laparotomy closure
03

In context

Colorectal Neoplasms

6,541 studies on the registry are indexed under Colorectal Neoplasms; 1,667 are open to participants now.

This study's planned enrollment of 218 is above the median of 76 across 4,800 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Suturion AB is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >18 years of age
  • Patients selected for elective surgical procedure through a midline incision due to colorectal disease

Exclusion criteria

Exclusion Criteria:

  • Previous surgery including the midline
  • Previous hernia including the midline
  • Collagen disease
  • Disseminated disease at the time of surgery
  • less than 1 year.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
218 participants (estimated)

Study arms

  • Active comparator
    Device assisted laparotomy closure

    38 patients undergoing elective treatment for colorectal diseases and abdominal wall closure with a device for standardized laparotomy closure

    Device: Device assisted laparotomy closure

  • Other
    Manual laparotomy closure

    180 patients undergoing elective treatment for colorectal diseases and abdominal wall closure by manual laparotomy closure

    Behavioral: Manual laparotomy closure

Interventions

  • DeviceDevice assisted laparotomy closure

    SutureTOOL is a single patient device for standardized laparotomy closure. The devices use a 2/0 polydioxanone suture and secures a small-bites closure.

    Also known as: SutureTOOL

  • BehavioralManual laparotomy closure

    Standard practice of laparotomy closure using standard needle driver and curved needle

06

What researchers measure

Primary outcomes

  1. Incisional hernia at 1-year

    Incisional hernia detected by review of CT-scan or clinical examination or chart review revealing incisional hernia.

    Time frame: 1-year

Secondary outcomes

  1. Wound infection

    Wound infection detected by reviewing patient chart

    Time frame: 30 days

  2. Suture length to wound length ratio

    Data collected by reviewing operative notes

    Time frame: At the surgical procedure date

  3. Wound dehiscence

    Wound dehiscence detected by review of patient chart.

    Time frame: 30 days from surgical procedure

  4. Death due to abdominal wall related complication

    Time frame: 30 days

Other outcomes

  1. Demographic data

    Demographic data retrieved from patients chart

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Anonymized data can be shared upon request

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: After publication

Access criteria: upon request

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Oct 2026, 3 months after the start.

Of 57 industry-sponsored interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 3 months is below that.

Counting every sponsor, half of 955 studies reached it within 32 months; a quarter within 14 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 10, 2026
First posted
Aug 14, 2026
StartActual
Jul 18, 2026
Primary completionEst.
Oct 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Sep 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07766044
Lead sponsor
Suturion AB
Collaborators
Lund University, Region Skåne Sweden
Responsible party
Gabriel Börner (Consultant surgeon, PhD in Surgery, Lund University) — Principal investigator
First posted
Aug 14, 2026
Start date
Jul 18, 2026
Primary completion
Oct 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Sep 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion